While the company reported positive revenue growth and improvements in adjusted EBITDA, significant challenges such as organic revenue decline, large net loss due to impairment, and substantial market headwinds contribute to a mixed outlook. The strategic reorganization and AI-driven initiatives are promising, but the impact of these efforts remains to be seen.
Company Guidance -
Q4 2025
During Simulations Plus' Third Quarter Fiscal 2025 Financial Results Conference Call, the company reported a 10% revenue growth to $20.4 million, bolstered by a $2.4 million contribution from the Pro-ficiency acquisition. However, organic revenue declined by 4%, mainly due to reduced QSP/QST software and biosimulation services revenue. Adjusted diluted EPS was $0.45, up from $0.27 last year, while adjusted EBITDA reached $7.4 million, or 37% of revenue. The company revised its full-year revenue guidance to $76-$80 million, with Pro-ficiency contributing $9-$12 million. While software revenue saw a 6% increase, driven by products like ADMET Predictor and GastroPlus, services revenue declined due to market headwinds and a significant client cancellation. Simulations Plus remains committed to growth in clinical operations and AI integration, despite a challenging biopharma market and anticipates a modest improvement in fiscal 2026.
Revenue Growth
Total revenue increased 10% to $20.4 million, with a $2.4 million contribution from the Pro-ficiency acquisition. Software revenue increased 6% and Services revenue increased 17%.
Software Performance
Software revenue grew 6% in the quarter, driven by ADMET Predictor solution and modest growth in GastroPlus and MonolixSuite platforms.
Adjusted EBITDA Improvement
Adjusted EBITDA was $7.4 million or 37% of revenue, compared to $5.6 million or 30% of revenue last year.
Strategic Reorganization
Transitioned from a business unit structure to a functionally driven operating model, expected to improve operational efficiency and better position for sustainable growth.
Simulations Plus (SLP) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SLP Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jul 14, 2025
$17.47
$12.97
-25.76%
Apr 03, 2025
$23.82
$25.68
+7.81%
Jan 07, 2025
$30.39
$28.21
-7.17%
Oct 23, 2024
$33.98
$30.96
-8.89%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Simulations Plus (SLP) report earnings?
Simulations Plus (SLP) is schdueled to report earning on Oct 22, 2025, After Close (Confirmed).
What is Simulations Plus (SLP) earnings time?
Simulations Plus (SLP) earnings time is at Oct 22, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.